Lido Advisors, LLC: CNR position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Lido Advisors, LLC on CNR, newest first. How the timeline and the estimate are built.
Lido Advisors, LLC held 2,548 CNR shares at 2026-06-30 per its 13F-HR filed 2026-08-07.
the latest 13F is the newest step
- period ended2026-06-3013F 2,548 sharesChange vs previous 13F -301 shares
<0.01% of the 13F portfolio, value $203,956.
13F-HR 0001172661-26-003159 filed by Lido Advisors, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 2,849 sharesChange vs previous 13F -93 shares
<0.01% of the 13F portfolio, value $298,454.
13F-HR 0001172661-26-001805 filed by Lido Advisors, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 2,942 sharesChange vs previous 13F -66 shares
<0.01% of the 13F portfolio, value $248,202.
13F-HR 0001172661-26-000582 filed by Lido Advisors, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 3,008 sharesChange vs previous 13F -44 shares
<0.01% of the 13F portfolio, value $251,152.
13F-HR 0001172661-25-004894 filed by Lido Advisors, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 3,052 sharesChange vs previous 13F -859 shares
<0.01% of the 13F portfolio, value $212,878.
13F-HR 0001172661-25-003111 filed by Lido Advisors, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 3,911 sharesChange vs previous 13F not available
<0.01% of the 13F portfolio, value $301,561.
13F-HR 0001172661-25-002184 filed by Lido Advisors, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).